287 related articles for article (PubMed ID: 27939967)
1. The effect of preoperative serum triglycerides and high-density lipoprotein-cholesterol levels on the prognosis of breast cancer.
Li X; Tang H; Wang J; Xie X; Liu P; Kong Y; Ye F; Shuang Z; Xie Z; Xie X
Breast; 2017 Apr; 32():1-6. PubMed ID: 27939967
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of preoperative serum high density lipoprotein cholesterol levels in soft tissue sarcoma.
Que Y; Jiang F; Liu L; Li Y; Chen Y; Qiu H; Zhou Z; Zhang X
Medicine (Baltimore); 2015 May; 94(18):e844. PubMed ID: 25950696
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of a reduction in the level of high-density lipoprotein-cholesterol in patients with non-small-cell lung cancer undergoing radical resection and adjuvant chemotherapy: a retrospective observational study.
Luo F; Zeng KM; Cao JX; Zhou T; Lin SX; Ma WJ; Yang YP; Zhang ZH; Lu FT; Huang Y; Zhao HY; Zhang L
Lipids Health Dis; 2021 Sep; 20(1):109. PubMed ID: 34544437
[TBL] [Abstract][Full Text] [Related]
4. Associations of preoperative serum high-density lipoprotein cholesterol and low-density lipoprotein cholesterol levels with the prognosis of ovarian cancer.
Lin Q; Liu W; Xu S; Sun L
Arch Gynecol Obstet; 2022 Mar; 305(3):683-691. PubMed ID: 34453586
[TBL] [Abstract][Full Text] [Related]
5. The clinical significance of preoperative serum cholesterol and high-density lipoprotein-cholesterol levels in hepatocellular carcinoma.
Jiang SS; Weng DS; Jiang L; Zhang YJ; Pan K; Pan QZ; Chen CL; Zhao JJ; Zhang XF; Zhang HX; Tang Y; Zhou ZQ; Chen MS; Xia JC
J Cancer; 2016; 7(6):626-32. PubMed ID: 27076843
[TBL] [Abstract][Full Text] [Related]
6. The clinical significance of preoperative serum triglyceride, high-density lipoprotein, and low-density lipoprotein levels in lung squamous cell carcinoma.
Li Z; Xu J; Feng W; Ma Z; Wu Y; Zhu T; Xu P; Dong L; Ding J; Zhou J; Yu G
Sci Rep; 2022 Oct; 12(1):16828. PubMed ID: 36207435
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of preoperative platelet-to-albumin ratio and apolipoprotein B-to-apolipoprotein A1 ratio for osteosarcoma in children and adolescents: a retrospective study of 118 cases.
Ma C; Li R; Yu R; Guo J; Xu J; Yuan X; Guo J
BMC Cancer; 2022 Jan; 22(1):113. PubMed ID: 35086516
[TBL] [Abstract][Full Text] [Related]
8. Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.
van den Berg MJ; van der Graaf Y; de Borst GJ; Kappelle LJ; Nathoe HM; Visseren FLJ;
Am J Cardiol; 2016 Sep; 118(6):804-810. PubMed ID: 27471056
[TBL] [Abstract][Full Text] [Related]
9. Serum lipids, lipoproteins, and risk of breast cancer: a nested case-control study using multiple time points.
Martin LJ; Melnichouk O; Huszti E; Connelly PW; Greenberg CV; Minkin S; Boyd NF
J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25817193
[TBL] [Abstract][Full Text] [Related]
10. Significance of alterations in plasma lipid profile levels in breast cancer.
Franky Dhaval Shah ; Shilin Nandubhai Shukla ; Pankaj Manubhai Shah ; Patel HR; Prabhudas Shankerbhai Patel
Integr Cancer Ther; 2008 Mar; 7(1):33-41. PubMed ID: 18292593
[TBL] [Abstract][Full Text] [Related]
11. The preoperative plasma fibrinogen level is an independent prognostic factor for overall survival of breast cancer patients who underwent surgical treatment.
Wen J; Yang Y; Ye F; Huang X; Li S; Wang Q; Xie X
Breast; 2015 Dec; 24(6):745-50. PubMed ID: 26482138
[TBL] [Abstract][Full Text] [Related]
12. Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low-Density Lipoprotein Cholesterol or Non-High-Density Lipoprotein Cholesterol.
Sniderman AD; Islam S; McQueen M; Pencina M; Furberg CD; Thanassoulis G; Yusuf S
J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27737874
[TBL] [Abstract][Full Text] [Related]
13. Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study.
Ren XY; Shi D; Ding J; Cheng ZY; Li HY; Li JS; Pu HQ; Yang AM; He CL; Zhang JP; Ma YB; Zhang YW; Zheng TZ; Bai YN; Cheng N
Lipids Health Dis; 2019 Feb; 18(1):47. PubMed ID: 30744645
[TBL] [Abstract][Full Text] [Related]
14. Reference intervals for six lipid analytes in 8-14 year-old school children from three different ethnical groups in the Hulun Buir area of China.
Du Y; Sun H; Li Y; Shi X; Pei D; Qi D; Wang B
Clin Lab; 2014; 60(8):1295-300. PubMed ID: 25185414
[TBL] [Abstract][Full Text] [Related]
15. LDL-C/apoB and HDL-C/apoA-1 ratios predict incident chronic kidney disease in a large apparently healthy cohort.
Bae JC; Han JM; Kwon S; Jee JH; Yu TY; Lee MK; Kim JH
Atherosclerosis; 2016 Aug; 251():170-176. PubMed ID: 27341533
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
[TBL] [Abstract][Full Text] [Related]
17. Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk.
His M; Zelek L; Deschasaux M; Pouchieu C; Kesse-Guyot E; Hercberg S; Galan P; Latino-Martel P; Blacher J; Touvier M
Eur J Epidemiol; 2014 Feb; 29(2):119-32. PubMed ID: 24519551
[TBL] [Abstract][Full Text] [Related]
18. Status of lipid and lipoprotein in female breast cancer patients at initial diagnosis and during chemotherapy.
Li X; Liu ZL; Wu YT; Wu H; Dai W; Arshad B; Xu Z; Li H; Wu KN; Kong LQ
Lipids Health Dis; 2018 Apr; 17(1):91. PubMed ID: 29678178
[TBL] [Abstract][Full Text] [Related]
19. The apoB100/apoAI ratio is independently associated with the severity of coronary heart disease: a cross sectional study in patients undergoing coronary angiography.
Song Y; Yang Y; Zhang J; Wang Y; He W; Zhang X; Zhu J; Lu Z
Lipids Health Dis; 2015 Nov; 14():150. PubMed ID: 26582246
[TBL] [Abstract][Full Text] [Related]
20. Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?
Liberopoulos E; Karabina SA; Tselepis A; Bairaktari E; Nicolaides C; Pavlidis N; Elisaf M
Oncology; 2002; 62(2):115-20. PubMed ID: 11914596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
